(EMR) Emerson Electric - Overview

Sector: Industrials | Industry: Specialty Industrial Machinery | Exchange: NYSE (USA) | Market Cap: 70.513m USD | Total Return: 31.4% in 12m

Stock Valves, Instrumentation, Automation, Tools, Software
Total Rating 50
Safety 85
Buy Signal -0.01
Specialty Industrial Machinery -8.1
Electrical Components & Equipment +0.2
Market Cap: 70,513m
Avg Trading Vol: 419M USD
ATR: 3.60%
Peers RS (IBD): 19.7
Risk 5d forecast
Volatility37.5%
Rel. Tail Risk-8.65%
Reward TTM
Sharpe Ratio0.63
Alpha-3.10
Character TTM
Beta1.518
Beta Downside1.767
Drawdowns 3y
Max DD29.62%
CAGR/Max DD0.60
EPS (Earnings per Share) EPS (Earnings per Share) of EMR over the last years for every Quarter: "2021-03": 0.97, "2021-06": 1.09, "2021-09": 1.21, "2021-12": 1.05, "2022-03": 1.29, "2022-06": 1.38, "2022-09": 1.53, "2022-12": 0.78, "2023-03": 1.09, "2023-06": 1.29, "2023-09": 1.29, "2023-12": 1.22, "2024-03": 1.36, "2024-06": 1.43, "2024-09": 1.48, "2024-12": 1.38, "2025-03": 1.48, "2025-06": 1.52, "2025-09": 1.62, "2025-12": 1.07,
EPS CAGR: -4.86%
EPS Trend: 30.1%
Last SUE: 0.94
Qual. Beats: 1
Revenue Revenue of EMR over the last years for every Quarter: 2021-03: 4431, 2021-06: 4697, 2021-09: 4947, 2021-12: 3156, 2022-03: 3291, 2022-06: 3465, 2022-09: 5360, 2022-12: 3373, 2023-03: 3756, 2023-06: 3946, 2023-09: 4090, 2023-12: 4117, 2024-03: 4376, 2024-06: 4380, 2024-09: 4619, 2024-12: 4175, 2025-03: 4432, 2025-06: 4553, 2025-09: 4855, 2025-12: 4345,
Rev. CAGR: 7.69%
Rev. Trend: 58.6%
Last SUE: -0.04
Qual. Beats: 0
Description: EMR Emerson Electric

Emerson Electric Co. (EMR) is a technology and software company operating globally. It serves diverse industries through six segments.

The Final Control segment provides valves and regulators for process and hybrid industries. The Measurement & Analytical segment offers intelligent instrumentation for measuring physical properties of liquids and gases, a core function in industrial automation. The Discrete Automation segment supplies components like valves and actuators for discrete manufacturing. The Safety & Productivity segment sells tools for professionals and homeowners, a business model that combines industrial and consumer markets. The Control Systems & Software segment delivers systems and software for plant process control. The Test & Measurement segment focuses on automated test and measurement systems.

For more detailed financial analysis and performance metrics, continue your research on ValueRay.

Headlines to Watch Out For
  • Industrial automation demand drives Final Control and Discrete Automation segments
  • Energy sector capital expenditure impacts Measurement & Analytical sales
  • Software and control systems adoption boosts recurring revenue
  • Global economic growth influences overall industrial spending
Piotroski VR‑10 (Strict) 7.0
Net Income: 2.31b TTM > 0 and > 6% of Revenue
FCF/TA: 0.06 > 0.02 and ΔFCF/TA -1.53 > 1.0
NWC/Revenue: -9.22% < 20% (prev 18.44%; Δ -27.66% < -1%)
CFO/TA 0.07 > 3% & CFO 3.02b > Net Income 2.31b
Net Debt (12.17b) to EBITDA (4.99b): 2.44 < 3
Current Ratio: 0.84 > 1.5 & < 3
Outstanding Shares: last quarter (564.1m) vs 12m ago -1.23% < -2%
Gross Margin: 51.66% > 18% (prev 0.52%; Δ 5.11k% > 0.5%)
Asset Turnover: 43.02% > 50% (prev 41.19%; Δ 1.83% > 0%)
Interest Coverage Ratio: 7.38 > 6 (EBITDA TTM 4.99b / Interest Expense TTM 450.0m)
Altman Z'' 5.41
A: -0.04 (Total Current Assets 8.84b - Total Current Liabilities 10.52b) / Total Assets 41.94b
B: 0.97 (Retained Earnings 40.87b / Total Assets 41.94b)
C: 0.08 (EBIT TTM 3.32b / Avg Total Assets 42.27b)
D: 1.87 (Book Value of Equity 40.52b / Total Liabilities 21.65b)
Altman-Z'' Score: 5.41 = AAA
Beneish M -2.95
DSRI: 1.06 (Receivables 2.97b/2.69b, Revenue 18.18b/17.55b)
GMI: 1.02 (GM 51.66% / 52.44%)
AQI: 1.00 (AQ_t 0.72 / AQ_t-1 0.72)
SGI: 1.04 (Revenue 18.18b / 17.55b)
TATA: -0.02 (NI 2.31b - CFO 3.02b) / TA 41.94b)
Beneish M-Score: -2.95 (Cap -4..+1) = A
What is the price of EMR shares? As of April 05, 2026, the stock is trading at USD 131.02 with a total of 4,997,928 shares traded.
Over the past week, the price has changed by +5.02%, over one month by -10.15%, over three months by -7.45% and over the past year by +31.41%.
Is EMR a buy, sell or hold? Emerson Electric has received a consensus analysts rating of 4.27. Therefore, it is recommended to buy EMR.
  • StrongBuy: 19
  • Buy: 3
  • Hold: 6
  • Sell: 1
  • StrongSell: 1
What are the forecasts/targets for the EMR price?
Wallstreet Target Price 165.8 26.5%
Analysts Target Price 165.8 26.5%
EMR Fundamental Data Overview as of 31 March 2026
P/E Trailing = 30.7353
P/E Forward = 19.6464
P/S = 3.8771
P/B = 3.5518
P/EG = 1.6379
Revenue TTM = 18.18b USD
EBIT TTM = 3.32b USD
EBITDA TTM = 4.99b USD
Long Term Debt = 7.58b USD (from longTermDebt, last quarter)
Short Term Debt = 5.83b USD (from shortTermDebt, last quarter)
Debt = 13.92b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 12.17b USD (from netDebt column, last quarter)
Enterprise Value = 82.68b USD (70.51b + Debt 13.92b - CCE 1.75b)
Interest Coverage Ratio = 7.38 (Ebit TTM 3.32b / Interest Expense TTM 450.0m)
EV/FCF = 32.11x (Enterprise Value 82.68b / FCF TTM 2.58b)
FCF Yield = 3.11% (FCF TTM 2.58b / Enterprise Value 82.68b)
FCF Margin = 14.16% (FCF TTM 2.58b / Revenue TTM 18.18b)
Net Margin = 12.72% (Net Income TTM 2.31b / Revenue TTM 18.18b)
Gross Margin = 51.66% ((Revenue TTM 18.18b - Cost of Revenue TTM 8.79b) / Revenue TTM)
Gross Margin QoQ = 48.56% (prev 51.91%)
Tobins Q-Ratio = 1.97 (Enterprise Value 82.68b / Total Assets 41.94b)
Interest Expense / Debt = 0.83% (Interest Expense 116.0m / Debt 13.92b)
Taxrate = 21.81% (169.0m / 775.0m)
NOPAT = 2.60b (EBIT 3.32b * (1 - 21.81%))
Current Ratio = 0.84 (Total Current Assets 8.84b / Total Current Liabilities 10.52b)
Debt / Equity = 0.69 (Debt 13.92b / totalStockholderEquity, last quarter 20.29b)
Debt / EBITDA = 2.44 (Net Debt 12.17b / EBITDA 4.99b)
Debt / FCF = 4.73 (Net Debt 12.17b / FCF TTM 2.58b)
Total Stockholder Equity = 19.92b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.47% (Net Income 2.31b / Total Assets 41.94b)
RoE = 11.61% (Net Income TTM 2.31b / Total Stockholder Equity 19.92b)
RoCE = 12.08% (EBIT 3.32b / Capital Employed (Equity 19.92b + L.T.Debt 7.58b))
RoIC = 7.73% (NOPAT 2.60b / Invested Capital 33.63b)
WACC = 9.56% (E(70.51b)/V(84.43b) * Re(11.32%) + D(13.92b)/V(84.43b) * Rd(0.83%) * (1-Tc(0.22)))
Discount Rate = 11.32% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.81%
[DCF] Terminal Value 71.23% ; FCFF base≈2.85b ; Y1≈2.60b ; Y5≈2.28b
[DCF] Fair Price = 35.10 (EV 31.90b - Net Debt 12.17b = Equity 19.72b / Shares 562.0m; r=9.56% [WACC]; 5y FCF grow -11.16% → 3.0% )
EPS Correlation: 30.09 | EPS CAGR: -4.86% | SUE: 0.94 | # QB: 1
Revenue Correlation: 58.58 | Revenue CAGR: 7.69% | SUE: -0.04 | # QB: 0
EPS next Quarter (2026-06-30): EPS=1.69 | Chg7d=-0.003 | Chg30d=-0.006 | Revisions Net=+3 | Analysts=21
EPS current Year (2026-09-30): EPS=6.51 | Chg7d=-0.006 | Chg30d=-0.009 | Revisions Net=-1 | Growth EPS=+8.5% | Growth Revenue=+5.2%
EPS next Year (2027-09-30): EPS=7.18 | Chg7d=-0.008 | Chg30d=-0.003 | Revisions Net=+1 | Growth EPS=+10.2% | Growth Revenue=+5.4%
[Analyst] Revisions Ratio: +0.23 (8 Up / 5 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 8.1% (Discount Rate 11.3% - Earnings Yield 3.3%)
[Growth] Growth Spread = -1.8% (Analyst 6.2% - Implied 8.1%)
External Resources
Dataroma Stockcircle